SEC Tracker
Get the app

Revolution Medicines RVMD

Patel Sushil (Director) plans to sell 5,580 RVMD shares, about $1M

Form
144
Filed
Importance
Routine
  1. Approximate sale date: Jun 29, 2026
  2. Broker: Morgan Stanley Smith Barney LLC Executive Financial Services
  3. Shares acquired by: Exercise of Stock Options; Restricted Stock Units
  4. 10b5-1 plan adopted: Mar 30, 2026

All of Patel Sushil's insider filings, holdings and planned sales

Form 4s that likely executed this notice (SEC Tracker's match by person, company, dates and shares):

  • Sold 300 shares at $183.17 on Jun 29, 2026 · Form 4
  • Sold 900 shares at $184.59 on Jun 29, 2026 · Form 4
  • Sold 1,100 shares at $185.9 on Jun 29, 2026 · Form 4
  • Sold 858 shares at $186.92 on Jun 29, 2026 · Form 4
  • Sold 300 shares at $187.83 on Jun 29, 2026 · Form 4
  • Sold 100 shares at $188.57 on Jun 29, 2026 · Form 4
  • Sold 600 shares at $190.55 on Jun 29, 2026 · Form 4
  • Sold 541 shares at $191.87 on Jun 29, 2026 · Form 4
  • Sold 881 shares at $192.61 on Jun 29, 2026 · Form 4

Written from the Form 144 on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when Revolution Medicines files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2836 and related industry codes: the same peer list as the financial tables.

  1. Biomarin Pharmaceutical BMRN public float $6.7B, Jun 30, 2025
  2. Jazz Pharmaceuticals JAZZ public float $6.3B, Jun 30, 2025
  3. Corcept Therapeutics CORT public float $6.1B, Jun 30, 2025
  4. Repligen RGEN public float $6.0B, Jun 30, 2025
  5. Madrigal Pharmaceuticals MDGL public float $5.6B, Jun 30, 2025